Cytochrome P450 expression and regulation in the brain

References

• Abdelgadir SE, Roselli CE, Choate JV, Resko JA. 1997. Distribution of aromatase cytochrome P450 messenger ribonucleic acid in adult rhesus monkey brains. Biol Reprod. 57(4):772–777.
   PubMed Web of Science ®Google Scholar
• Abdel-Razzak Z, Corcos L, Fautrel A, Campion JP, Guillouzo A. 1994. Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture. Mol Pharmacol. 46(6):1100–1110.
   PubMed Web of Science ®Google Scholar
• Abu-Qare AW, Abou-Donia MB. 2001. DEET (N,N-diethyl-m-toluamide) alone and in combination with permethrin increased urinary excretion of 6beta-hydroxycortisol in rats, a marker of hepatic CYP3A induction. J Toxicol Environ Health A. 64(5):373–384.
   PubMed Web of Science ®Google Scholar
• Acuña-Castroviejo D, Escames G, Venegas C, Díaz-Casado ME, Lima-Cabello E, López LC, Rosales-Corral S, Tan D-X, Reiter RJ. 2014. Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci. 71(16):2997–3025.
   PubMed Web of Science ®Google Scholar
• Adesnik M, Bar-Nun S, Maschio F, Zunich M, Lippman A, Bard E. 1981. Mechanism of induction of cytochrome P-450 by phenobarbital. J Biol Chem. 256(20):10340–10345.
   PubMed Web of Science ®Google Scholar
• Agarwal V, Kommaddi RP, Valli K, Ryder D, Hyde TM, Kleinman JE, Strobel HW, Ravindranath V. 2008. Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metabolite. PLoS One. 3(6):e2337
   PubMed Web of Science ®Google Scholar
• Akashi M, Takumi T. 2005. The orphan nuclear receptor RORalpha regulates circadian transcription of the mammalian core-clock Bmal1. Nat Struct Mol Biol. 12(5):441–448.
   PubMed Web of Science ®Google Scholar
• Al Koudsi N, Hoffmann EB, Assadzadeh A, Tyndale RF. 2010. Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors. Eur J Clin Pharmacol. 66(3):239–251.
   PubMed Web of Science ®Google Scholar
• Alkayed NJ, Birks EK, Hudetz AG, Roman RJ, Henderson L, Harder DR. 1996. Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow. Am J Physiol. 271(4 Pt 2):H1541–1546.
   PubMedGoogle Scholar
• Anakk S, Kalsotra A, Kikuta Y, Huang W, Zhang J, Staudinger JL, Moore DD, Strobel HW. 2004. CAR/PXR provide directives for Cyp3a41 gene regulation differently from Cyp3a11. Pharmacogenomics J. 4(2):91–101.
   PubMed Web of Science ®Google Scholar
• Anandatheerthavarada HK, Williams JF, Wecker L. 1993. The chronic administration of nicotine induces cytochrome P450 in rat brain. J Neurochem. 60(5):1941–1944.
   PubMed Web of Science ®Google Scholar
• Annalora AJ, Marcus CB, Iversen PL. 2017. Alternative splicing in the cytochrome P450 superfamily expands protein diversity to augment gene function and redirect human drug metabolism. Drug Metab Dispos. 45(4):375–389.
   PubMed Web of Science ®Google Scholar
• Bauer B, Hartz AMS, Fricker G, Miller DS. 2004. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol. 66(3):413–419.
   PubMed Web of Science ®Google Scholar
• Baulieu E-E, Schumacher M. 2000. Progesterone as a neuroactive neurosteroid, with special reference to the effect of progesterone on myelination. Steroids. 65(10-11):605–612.
   PubMed Web of Science ®Google Scholar
• Baum LO, Strobel HW. 1997. Regulation of expression of cytochrome P-450 2D mRNA in rat brain with steroid hormones. Brain Res. 765(1):67–73.
   PubMed Web of Science ®Google Scholar
• Bedford FK, Julius D, Ingraham HA. 1998. Neuronal expression of the 5HT 3 serotonin receptor gene requires nuclear factor 1 complexes. J Neurosci. 18(16):6186–6194.
   PubMed Web of Science ®Google Scholar
• Behm M, Öhman M. 2016. RNA editing: a contributor to neuronal dynamics in the mammalian brain. Trends Genet. 32(3):165–175.
   PubMed Web of Science ®Google Scholar
• Bhagwat SV, Boyd MR, Ravindranath V. 2000. Multiple forms of cytochrome P450 and associated monooxygenase activities in human brain mitochondria. Biochem Pharmacol. 59(5):573–582.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya MH, DeLuca HF. 1973. The regulation of rat liver calciferol-25-hydroxylase. J Biol Chem. 248(9):2969–2973.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya MH, DeLuca HF. 1974. Subcellular location of rat liver calciferol-25-hydroxylase. Arch Biochem Biophys. 160(1):58–62.
   PubMed Web of Science ®Google Scholar
• Björkhem I, Lütjohann D, Breuer O, Sakinis A, Wennmalm A. 1997. Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro. J Biol Chem. 272(48):30178–30184.
   PubMed Web of Science ®Google Scholar
• Booth Depaz IM, Toselli F, Wilce PA, Gillam EMJ. 2015. Differential expression of cytochrome P450 enzymes from the CYP2C subfamily in the human brain. Drug Metab Dispos. 43(3):353–357.
   PubMed Web of Science ®Google Scholar
• Boukhtouche F, Janmaat S, Vodjdani G, Gautheron V, Mallet J, Dusart I, Mariani J. 2006. Retinoid-related orphan receptor alpha controls the early steps of Purkinje cell dendritic differentiation. J Neurosci. 26(5):1531–1538.
   PubMed Web of Science ®Google Scholar
• Britto MR, Wedlund PJ. 1992. Cytochrome P-450 in the brain. Potential evolutionary and therapeutic relevance of localization of drug-metabolizing enzymes. Drug Metab Dispos. 20(3):446–450.
   PubMed Web of Science ®Google Scholar
• Bromek E, Haduch A, Gołembiowska K, Daniel WA. 2011. Cytochrome P450 mediates dopamine formation in the brain in vivo: dopamine formation by brain cytochrome P450 in vivo. J Neurochem. 118(5):806–815.
   PubMed Web of Science ®Google Scholar
• Casafont I, Palanca A, Lafarga V, Berciano MT, Lafarga M. 2011. Effect of ionizing radiation in sensory ganglion neurons: organization and dynamics of nuclear compartments of DNA damage/repair and their relationship with transcription and cell cycle. Acta Neuropathol. 122(4):481–493.
   PubMed Web of Science ®Google Scholar
• Ceccatelli S, Villar MJ, Goldstein M, Hökfelt T. 1989. Expression of c-Fos immunoreactivity in transmitter-characterized neurons after stress. Proc Natl Acad Sci USA. 86(23):9569–9573.
   PubMed Web of Science ®Google Scholar
• Chace C, Pang D, Weng C, Temkin A, Lax S, Silverman W, Zigman W, Ferin M, Lee JH, Tycko B, et al. 2012. Variants in CYP17 and CYP19 Cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome. J Alzheimers Dis. 28(3):601–612.
   PubMed Web of Science ®Google Scholar
• Chacos N, Capdevila J, Falck JR, Manna S, Martin-Wixtrom C, Gill SS, Hammock BD, Estabrook RW. 1983. The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with a cytosolic epoxide hydrolase. Arch Biochem Biophys. 223(2):639–648.
   PubMed Web of Science ®Google Scholar
• Chan GNY, Hoque MT, Cummins CL, Bendayan R. 2011. Regulation of P-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells. J Neurochem. 118(2):163–175.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay M, Chowdhury AR, Feng T, Assenmacher CA, Radaelli E, Guengerich FP, Avadhani NG. 2019. Mitochondrially targeted cytochrome P450 2D6 is involved in monomethylamine-induced neuronal damage in mouse models. J Biol Chem. 294(26):10336–10348.
   PubMed Web of Science ®Google Scholar
• Chen H, Howald WN, Juchau MR. 2000. Biosynthesis of all-trans-retinoic acid from all-trans-retinol: Catalysis of all-trans-retinol oxidation by human P-450 cytochromes. Drug Metab Dispos. 28(3):315–322.
   PubMed Web of Science ®Google Scholar
• Chen J-K, Chen J, Imig JD, Wei S, Hachey DL, Guthi JS, Falck JR, Capdevila JH, Harris RC. 2008. Identification of Novel Endogenous Cytochrome P450 Arachidonate Metabolites with High Affinity for Cannabinoid Receptors. J Biol Chem. 283(36):24514–24524.
   PubMed Web of Science ®Google Scholar
• Chen X, Wang H, Zhou G, Zhang X, Dong X, Zhi L, Jin L, He F. 2009. Molecular population genetics of human CYP3A locus: signatures of positive selection and implications for evolutionary environmental medicine. Environ Health Perspect. 117(10):1541–1548.
   PubMed Web of Science ®Google Scholar
• Chen Y, Coulter S, Jetten AM, Goldstein JA. 2009. Identification of human CYP2C8 as a retinoid-related orphan nuclear receptor target gene. J Pharmacol Exp Ther. 329(1):192–201.
   PubMed Web of Science ®Google Scholar
• Chen Y, Kissling G, Negishi M, Goldstein JA. 2005. The nuclear receptors constitutive androstane receptor and pregnane x receptor cross-talk with hepatic nuclear factor 4alpha to synergistically activate the human CYP2C9 promoter. J Pharmacol Exp Ther. 314(3):1125–1133.
   PubMed Web of Science ®Google Scholar
• Cheng J, Zhen Y, Miksys S, Beyoğlu D, Krausz KW, Tyndale RF, Yu A, Idle JR, Gonzalez FJ. 2013. Potential role of CYP2D6 in the central nervous system. Xenobiotica. 43(11):973–984.
   PubMed Web of Science ®Google Scholar
• Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW. 2003. De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase. J Biol Chem. 278(39):38084–38093.
   PubMed Web of Science ®Google Scholar
• Cheong RY, Czieselsky K, Porteous R, Herbison AE. 2015. Expression of ESR1 in Glutamatergic and GABAergic Neurons Is Essential for Normal Puberty Onset, Estrogen Feedback, and Fertility in Female Mice. J Neurosci. 35(43):14533–14543.
   PubMed Web of Science ®Google Scholar
• Cheung C, Ma X, Krausz KW, Kimura S, Feigenbaum L, Dalton TP, Nebert DW, Idle JR, Gonzalez FJ. 2005. Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2. Chem Res Toxicol. 18(9):1471–1478.
   PubMed Web of Science ®Google Scholar
• Chi SW, Zang JB, Mele A, Darnell RB. 2009. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature. 460(7254):479–486.
   PubMed Web of Science ®Google Scholar
• Chiaro CR, Patel RD, Marcus CB, Perdew GH. 2007. Evidence for an aryl hydrocarbon receptor-mediated cytochrome P450 autoregulatory pathway. Mol Pharmacol. 72(5):1369–1379.
   PubMed Web of Science ®Google Scholar
• Chinta SJ, Kommaddi RP, Turman CM, Strobel HW, Ravindranath V. 2005. Constitutive expression and localization of cytochrome P-450 1A1 in rat and human brain: presence of a splice variant form in human brain1. J Neurochem. 93(3):724–736.
   PubMed Web of Science ®Google Scholar
• Chinta SJ, Pai HV, Upadhya SC, Boyd MR, Ravindranath V. 2002. Constitutive expression and localization of the major drug metabolizing enzyme, cytochrome P4502D in human brain. Brain Res Mol Brain Res. 103(1–2):49–61.
   PubMedGoogle Scholar
• Choudhary D, Jansson I, Stoilov I, Sarfarazi M, Schenkman JB. 2004. Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1B1. Drug Metab Dispos. 32(8):840–847.
   PubMed Web of Science ®Google Scholar
• Chowdhury GM, Fujioka T, Nakamura S. 2000. Induction and adaptation of Fos expression in the rat brain by two types of acute restraint stress. Brain Res Bull. 52(3):171–182.
   PubMed Web of Science ®Google Scholar
• Chuang SS, Helvig C, Taimi M, Ramshaw HA, Collop AH, Amad M, White JA, Petkovich M, Jones G, Korczak B. 2004. CYP2U1, a Novel Human Thymus- and Brain-specific Cytochrome P450, Catalyzes omega- and (omega-1)-hydroxylation of fatty acids. J Biol Chem. 279(8):6305–6314.
   PubMed Web of Science ®Google Scholar
• Claudel T, Cretenet G, Saumet A, Gachon F. 2007. Crosstalk between xenobiotics metabolism and circadian clock. FEBS Lett. 581(19):3626–3633.
   PubMed Web of Science ®Google Scholar
• Cojocaru V, Winn PJ, Wade RC. 2007. The ins and outs of cytochrome P450s. Biochim Biophys Acta BBA - Gen Subj. 1770(3):390–401.
   PubMed Web of Science ®Google Scholar
• Cook ND. 2008. The neuron-level phenomena underlying cognition and consciousness: synaptic activity and the action potential. Neuroscience. 153(3):556–570.
   PubMed Web of Science ®Google Scholar
• Corchero J, Pimprale S, Kimura S, Gonzalez FJ. 2001. Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation. Pharmacogenetics. 11(1):1–6.
   PubMedGoogle Scholar
• Cosgrove KP, Mazure CM, Staley JK. 2007. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry. 62(8):847–855.
   PubMed Web of Science ®Google Scholar
• Daly A. CYP2 family [Video file]. In: The Biomedical & Life Sciences Collection, Henry Stewart Talks; 2016 [accessed 2020 Sep 15]. Available from: https://hstalks.com/bs/685/.
   Google Scholar
• Daniel WA. 2005. The influence of long-term treatment with psychotropic drugs on cytochrome P450: the involvement of different mechanisms. Expert Opin Drug Metab Toxicol. 1(2):203–217.
   PubMedGoogle Scholar
• Daniel WA, Haduch A, Wójcikowski J. 2005. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms. Eur Neuropsychopharmacol. 15(1):103–110.
   PubMed Web of Science ®Google Scholar
• Das ML, Orrenius S, Ernster L. 1968. On the fatty acid and hydrocarbon hydroxylation in rat liver microsomes. Eur J Biochem. 4(4):519–523.
   PubMedGoogle Scholar
• Dauchy S, Dutheil F, Weaver RJ, Chassoux F, Daumas ‐Duport C, Couraud P-O, Scherrmann J-M, Waziers ID, Declèves X. 2008. ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem. 107(6):1518–1528.
   PubMed Web of Science ®Google Scholar
• Deneen B, Ho R, Lukaszewicz A, Hochstim CJ, Gronostajski RM, Anderson DJ. 2006. The Transcription Factor NFIA Controls the Onset of Gliogenesis in the Developing Spinal Cord. Neuron. 52(6):953–968.
   PubMed Web of Science ®Google Scholar
• Dhers L, Ducassou L, Boucher J-L, Mansuy D. 2017. Cytochrome P450 2U1, a very peculiar member of the human P450s family. Cell Mol Life Sci. 74(10):1859–1869.
   PubMed Web of Science ®Google Scholar
• Dluzen DF, Lazarus P. 2015. MicroRNA regulation of the major drug-metabolizing enzymes and related transcription factors. Drug Metab Rev. 47(3):320–334.
   PubMed Web of Science ®Google Scholar
• Doddapaneni H, Chakraborty R, Yadav JS. 2005. Genome-wide structural and evolutionary analysis of the P450 monooxygenase genes (P450ome) in the white rot fungus Phanerochaete chrysosporium: evidence for gene duplications and extensive gene clustering. BMC Genomics. 6:92
   PubMed Web of Science ®Google Scholar
• Dorado P, Peñas-Lledó EM, Llerena A. 2007. CYP2D6 polymorphism: implications for antipsychotic drug response, schizophrenia and personality traits. Pharmacogenomics. 8(11):1597–1608.
   PubMed Web of Science ®Google Scholar
• Dutheil F, Beaune P, Loriot M-A. 2008. Xenobiotic metabolizing enzymes in the central nervous system: Contribution of cytochrome P450 enzymes in normal and pathological human brain. Biochimie. 90(3):426–436.
   PubMed Web of Science ®Google Scholar
• Dutheil F, Dauchy S, Diry M, Sazdovitch V, Cloarec O, Mellottée L, Bièche I, Ingelman-Sundberg M, Flinois J-P, de Waziers I, et al. 2009. Xenobiotic-Metabolizing Enzymes and Transporters in the Normal Human Brain: Regional and Cellular Mapping as a Basis for Putative Roles in Cerebral Function. Drug Metab Dispos. 37(7):1528–1538.
   PubMed Web of Science ®Google Scholar
• Erdozain AM, Morentin B, Bedford L, King E, Tooth D, Brewer C, Wayne D, Johnson L, Gerdes HK, Wigmore P, et al. 2014. Alcohol-Related Brain Damage in Humans. PLoS One [Internet]. [accessed 2020 Feb 26] 9(4):e93586.
   PubMed Web of Science ®Google Scholar
• Essex MJ, Boyce WT, Hertzman C, Lam LL, Armstrong JM, Neumann SMA, Kobor MS. 2013. Epigenetic vestiges of early developmental adversity: childhood stress exposure and DNA methylation in adolescence. Child Dev. 84(1):58–75.
   PubMed Web of Science ®Google Scholar
• Estabrook RW, Cooper DY, Rosenthal O. 1963. THE light reversible carbon monoxide inhibition of the steroid C21-hydroxylase system of the adrenal cortex. Biochem Z. 338:741–755.
   PubMedGoogle Scholar
• Evans WE, Relling MV. 1999. Pharmacogenomics: translating functional genomics into rational therapeutics. Science. 286(5439):487–491.
   PubMed Web of Science ®Google Scholar
• Evert BO, Nalavade R, Jungverdorben J, Matthes F, Weber S, Rajput A, Bonn S, Brüstle O, Peitz M, Krauß S. 2018. Upregulation of miR-370 and miR-543 is associated with reduced expression of heat shock protein 40 in spinocerebellar ataxia type 3. PLoS One. 13(8):e0201794
   PubMed Web of Science ®Google Scholar
• Farin FM, Omiecinski CJ. 1993. Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue. J Toxicol Environ Health. 40(2–3):317–335.
   PubMed Web of Science ®Google Scholar
• Feng J, Zhou Y, Campbell SL, Le T, Li E, Sweatt JD, Silva AJ, Fan G. 2010. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci. 13(4):423–430.
   PubMed Web of Science ®Google Scholar
• Ferguson CS, Miksys S, Palmour RM, Tyndale RF. 2013. Ethanol self-administration and nicotine treatment induce brain levels of CYP2B6 and CYP2E1 in African green monkeys. Neuropharmacology. 72:74–81.
   PubMed Web of Science ®Google Scholar
• Ferguson SS, Chen Y, LeCluyse EL, Negishi M, Goldstein JA. 2005. Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4alpha. Mol Pharmacol. 68(3):747–757.
   PubMed Web of Science ®Google Scholar
• Fernandez-Abascal J, Ripullone M, Valeri A, Leone C, Valoti M. 2018. β-Naphtoflavone and Ethanol Induce Cytochrome P450 and Protect towards MPP + Toxicity in Human Neuroblastoma SH-SY5Y Cells. IJMS. 19(11):3369.
   Web of Science ®Google Scholar
• Feyereisen R. 2011. Arthropod CYPomes illustrate the tempo and mode in P450 evolution. Biochim Biophys Acta BBA - Proteins Proteomics. 1814(1):19–28.
   PubMed Web of Science ®Google Scholar
• Finta C, Zaphiropoulos PG. 2000. The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. Gene. 260(1-2):13–23.
   PubMed Web of Science ®Google Scholar
• Frohman LA, Downs TR, Chomczynski P. 1992. Regulation of growth hormone secretion. Front Neuroendocrinol. 13(4):344–405.
   PubMed Web of Science ®Google Scholar
• Fujii-Kuriyama Y, Mizukami Y, Kawajiri K, Sogawa K, Muramatsu M. 1982. Primary structure of a cytochrome P-450: coding nucleotide sequence of phenobarbital-inducible cytochrome P-450 cDNA from rat liver. Proc Natl Acad Sci USA. 79(9):2793–2797.
   PubMed Web of Science ®Google Scholar
• Fukushima M, Nishii Y, Suzukit M. 1978. Comparative studies on the 25-hydroxylations of cholecalciferol and La-hydroxycholecalciferol in perfused rat liver. Biochem J. 170(3):495–502.
   PubMed Web of Science ®Google Scholar
• Gachon F, Fonjallaz P, Damiola F, Gos P, Kodama T, Zakany J, Duboule D, Petit B, Tafti M, Schibler U. 2004. The loss of circadian PAR bZip transcription factors results in epilepsy. Genes Dev. 18(12):1397–1412.
   PubMed Web of Science ®Google Scholar
• Gachon F, Olela FF, Schaad O, Descombes P, Schibler U. 2006. The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification. Cell Metab. 4(1):25–36.
   PubMed Web of Science ®Google Scholar
• Galijatovic A, Beaton D, Nguyen N, Chen S, Bonzo J, Johnson R, Maeda S, Karin M, Guengerich FP, Tukey RH. 2004. The human CYP1A1 gene is regulated in a developmental and tissue-specific fashion in transgenic mice. J Biol Chem. 279(23):23969–23976.
   PubMed Web of Science ®Google Scholar
• Garcia ANM, Muniz MTC, Souza e Silva HR, da Silva HA, Athayde-Junior L. 2009. Cyp46 polymorphisms in Alzheimer's disease: a review. J Mol Neurosci. 39(3):342–345.
   PubMed Web of Science ®Google Scholar
• Garcia KLP, Coen K, Miksys S, Lê AD, Tyndale RF. 2015. Effect of brain CYP2B inhibition on brain nicotine levels and nicotine self-administration. Neuropsychopharmacol. 40(8):1910–1918.
   PubMed Web of Science ®Google Scholar
• García-Suástegui WA, Ramos-Chávez LA, Rubio-Osornio M, Calvillo-Velasco M, Atzin-Méndez JA, Guevara J, Silva-Adaya D. 2017. The role of CYP2E1 in the drug metabolism or bioactivation in the Brain. Romero FJ, editor. Oxid Med Cell Longev. 2017:4680732.
   PubMed Web of Science ®Google Scholar
• Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, et al. 2001. Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics. 11(2):111–121.
   PubMedGoogle Scholar
• Gervot L, Rochat B, Gautier JC, Bohnenstengel F, Kroemer H, de Berardinis V, Martin H, Beaune P, de Waziers I. 1999. Human CYP2B6: expression, inducibility and catalytic activities. Pharmacogenetics. 9(3):295–306.
   PubMedGoogle Scholar
• Ghaedi A, Keshavarzi M, Ghafarian Bahraman A, Mohammadi-Bardbori A. 2020. Selective cytochrome P450 1A1 but not 1B1 promoterCpG island DNA methylation by 6-formylindolo[3,2-b]carbazole (FICZ). J Biochem Mol Toxicol. 34(1):e22414.
   PubMed Web of Science ®Google Scholar
• Ghosh C, Hossain M, Solanki J, Najm IM, Marchi N, Janigro D. 2017. Overexpression of pregnane X and glucocorticoid receptors and the regulation of cytochrome P450 in human epileptic brain endothelial cells. Epilepsia. 58(4):576–585.
   PubMed Web of Science ®Google Scholar
• Giguère V, Tini M, Flock G, Ong E, Evans RM, Otulakowski G. 1994. Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev. 8(5):538–553.
   PubMed Web of Science ®Google Scholar
• Gilham DE, Cairns W, Paine MJ, Modi S, Poulsom R, Roberts GC, Wolf CR. 1997. Metabolism of MPTP by cytochrome P4502D6 and the demonstration of 2D6 mRNA in human foetal and adult brain by in situ hybridization. Xenobiotica. 27(1):111–125.
   PubMed Web of Science ®Google Scholar
• Gokhale MS, Bunton TE, Zurlo J, Yager JD. 1997. Cytochrome P450 isoenzyme activities in cultured rat and mouse liver slices. Xenobiotica. 27(4):341–355.
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ. 2008. Regulation of hepatocyte nuclear factor 4 alpha-mediated transcription. Drug Metab Pharmacokinet. 23(1):2–7.
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ, Kimura S. 2001. Understanding the role of xenobiotic-metabolism in chemical carcinogenesis using gene knockout mice. Mutat Res. 477(1–2):79–87.
   PubMed Web of Science ®Google Scholar
• Gotoh O. 1992. Substrate recognition sites in cytochrome P450 Family 2 (CYPB) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J Biol Chem. 267(1):83–90.
   PubMed Web of Science ®Google Scholar
• Gray IC, Nobile C, Muresu R, Ford S, Spurr NK. 1995. A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24. Genomics. 28(2):328–332.
   PubMed Web of Science ®Google Scholar
• Guillaumond F, Dardente H, Giguère V, Cermakian N. 2005. Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms. 20(5):391–403.
   PubMed Web of Science ®Google Scholar
• Guo J, Xiang Q, Xin Y, Huang Y, Zou G, Liu T. 2020. miR-544 promotes maturity and antioxidation of stem cell-derived endothelial like cells by regulating the YY1/TET2 signalling axis. Cell Commun Signal. 18(1):35.
   PubMed Web of Science ®Google Scholar
• Guo JU, Ma DK, Mo H, Ball MP, Jang M-H, Bonaguidi MA, Balazer JA, Eaves HL, Xie B, Ford E, et al. 2011. Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat Neurosci. 14(10):1345–1351.
   PubMed Web of Science ®Google Scholar
• Haduch A, Bromek E, Daniel WA. 2011. The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain. Eur J Pharmacol. 651(1–3):51–58.
   PubMed Web of Science ®Google Scholar
• Haduch A, Bromek E, Kot M, Kamińska K, Gołembiowska K, Daniel WA. 2015. The cytochrome P450 2D-mediated formation of serotonin from 5-methoxytryptamine in the brain in vivo: a microdialysis study. J Neurochem. 133(1):83–92.
   PubMed Web of Science ®Google Scholar
• Haduch A, Bromek E, Sadakierska-Chudy A, Wójcikowski J, Daniel WA. 2013. The catalytic competence of cytochrome P450 in the synthesis of serotonin from 5-methoxytryptamine in the brain: an in vitro study. Pharmacol Res. 67(1):53–59.
   PubMed Web of Science ®Google Scholar
• Haduch A, Bromek E, Wojcikowski J, Go Embiowska K, Daniel WA. 2016. Melatonin supports CYP2D-mediated serotonin synthesis in the brain. Drug Metab Dispos. 44(3):445–452.
   PubMed Web of Science ®Google Scholar
• Haduch A, Pukło R, Alenina N, Nikiforuk A, Popik P, Bader M, Daniel WA. 2020. The effect of ageing and cerebral serotonin deficit on the activity of cytochrome P450 2D (CYP2D) in the brain and liver of male rats. Neurochem Int. 141:104884.
   PubMed Web of Science ®Google Scholar
• Haduch A, Rysz M, Papp M, Daniel WA. 2018. The activity of brain and liver cytochrome P450 2D (CYP2D) is differently affected by antidepressants in the chronic mild stress (CMS) model of depression in the rat. Biochem Pharmacol. 156:398–405.
   PubMed Web of Science ®Google Scholar
• Haduch A, Wójcikowski J, Daniel WA. 2004. Effects of chronic treatment with classic and newer antidepressants and neuroleptics on the activity and level of CYP2D in the rat brain. Pol J Pharmacol. 56(6):857–862.
   PubMedGoogle Scholar
• Hagemeyer CE, Rosenbrock H, Ditter M, Knoth R, Volk B. 2003. Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain. Neuroscience. 117(3):521–529.
   PubMed Web of Science ®Google Scholar
• Hansson T, Tindberg N, Ingelman-Sundberg M, KöHler C. 1990. Regional distribution of ethanol-inducible cytochrome P450 IIE1 in the rat central nervous system. Neuroscience. 34(2):451–463.
   PubMed Web of Science ®Google Scholar
• Hardeland R. 2010. Melatonin metabolism in the central nervous system. Curr Neuropharmacol. 8(3):168–181.
   PubMed Web of Science ®Google Scholar
• Hardwick JP, Schwalm F, Richardson A. 1983. The effect of phenobarbital on the transcriptional activity of liver. Biochem J. 210(2):599–606.
   PubMed Web of Science ®Google Scholar
• He X, Zhang Z, Zhang J-W, Zhou Y, Wu C, Tang M, Hong Z. 2012. An intronic CYP46A1 polymorphism is associated with Alzheimer disease in a Chinese Han population. J Mol Neurosci. 47(3):514–518.
   PubMed Web of Science ®Google Scholar
• Hedlund E, Gustafsson J, Warner M. 2001. Cytochrome P450 in the brain: a review. Curr Drug Metab. 2(3):245–263.
   PubMed Web of Science ®Google Scholar
• Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, et al. 2007. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet. 39(3):311–318.
   PubMed Web of Science ®Google Scholar
• Herdegen T, Skene P, Bähr M. 1997. The c-Jun transcription factor-bipotential mediator of neuronal death, survival and regeneration. Trends Neurosci. 20(5):227–231.
   PubMed Web of Science ®Google Scholar
• Hiroi T, Imaoka S, Funae Y. 1998. Dopamine formation from tyramine by CYP2D6. Biochem Biophys Res Commun. 249(3):838–843.
   PubMed Web of Science ®Google Scholar
• Hoffman SM, Nelson DR, Keeney DS. 2001. Organization, structure and evolution of the CYP2 gene cluster on human chromosome 19. Pharmacogenetics. 11(8):687–698
   PubMedGoogle Scholar
• Hojo Y, Hattori T, Enami T, Furukawa A, Suzuki K, Ishii H, Mukai H, Morrison JH, Janssen WGM, Kominami S, et al. 2004. Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017alpha and P450 aromatase localized in neurons. Proc Natl Acad Sci USA. 101(3):865–870.
   PubMed Web of Science ®Google Scholar
• Hon GC, Hawkins RD, Caballero OL, Lo C, Lister R, Pelizzola M, Valsesia A, Ye Z, Kuan S, Edsall LE, et al. 2012. Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. Genome Res. 22(2):246–258.
   PubMed Web of Science ®Google Scholar
• Howard LA, Miksys S, Hoffmann E, Mash D, Tyndale RF. 2003. Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics. Br J Pharmacol. 138(7):1376–1386.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang J, Hu W, Wang C, Lu X, Tong L, Wu F, Zhang W. 2016. Identification of functional farnesoid X receptors in brain neurons. FEBS Lett. 590(18):3233–3242.
   PubMed Web of Science ®Google Scholar
• Huang P, Rannug A, Ahlbom E, Håkansson H, Ceccatelli S. 2000. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the expression of cytochrome P450 1A1, the aryl hydrocarbon receptor, and the aryl hydrocarbon receptor nuclear translocator in rat brain and pituitary. Toxicol Appl Pharmacol. 169(2):159–167.
   PubMed Web of Science ®Google Scholar
• Iliff JJ, Close LN, Selden NR, Alkayed NJ. 2007. A novel role for P450 eicosanoids in the neurogenic control of cerebral blood flow in the rat. Exp Physiol. 92(4):653–658.
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M. 2005. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J. 5(1):6–13.
   PubMed Web of Science ®Google Scholar
• Ino H. 2004. Immunohistochemical characterization of the orphan nuclear receptor ROR alpha in the mouse nervous system. J Histochem Cytochem. 52(3):311–323.
   PubMed Web of Science ®Google Scholar
• Ishii G, Suzuki A, Oshino S, Shiraishi H, Otani K. 2007. CYP2C19 polymorphism affects personality traits of Japanese females. Neurosci Lett. 411(1):77–80.
   PubMed Web of Science ®Google Scholar
• Jackson JP, Ferguson SS, Moore R, Negishi M, Goldstein JA. 2004. The constitutive active/androstane receptor regulates phenytoin induction of Cyp2c29. Mol Pharmacol. 65(6):1397–1404.
   PubMed Web of Science ®Google Scholar
• Jackson JP, Ferguson SS, Negishi M, Goldstein JA. 2006. Phenytoin induction of the cyp2c37 gene is mediated by the constitutive androstane receptor. Drug Metab Dispos. 34(12):2003–2010.
   PubMed Web of Science ®Google Scholar
• Janmohamed A, Dolphin CT, Phillips IR, Shephard EA. 2001. Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450. Biochem Pharmacol. 62(6):777–786.
   PubMed Web of Science ®Google Scholar
• Jia F, Liu Z, Song N, Du X, Xie J, Jiang H. 2016. The association between CYP46A1 rs4900442 polymorphism and the risk of Alzheimer's disease: A meta-analysis. Neurosci Lett. 620:83–87.
   PubMed Web of Science ®Google Scholar
• Jorge-Nebert LF, Jiang Z, Chakraborty R, Watson J, Jin L, McGarvey ST, Deka R, Nebert DW. 2010. Analysis of Human CYP1A1 and CYP1A2 Genes and Their Shared Bidirectional Promoter in Eight World Populations. Hum Mutat. 31(1):27–40.
   PubMed Web of Science ®Google Scholar
• Josephy PD, Bibeau KL, Evans DH. 2000. Activation of MeIQ (2-amino-3,4-dimethylimidazo- [4,5-f]quinoline) by sequence variants of recombinant human cytochrome P450 1A2. Environ Mol Mutagen. 35(4):328–335.
   PubMed Web of Science ®Google Scholar
• Joshi M, Tyndale RF. 2006. Regional and cellular distribution of CYP2E1 in monkey brain and its induction by chronic nicotine. Neuropharmacology. 50(5):568–575.
   PubMed Web of Science ®Google Scholar
• Jover R, Bort R, Gómez-Lechón MJ, Castell JV. 1998. Re-expression of C/EBP alpha induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells. FEBS Lett. 431(2):227–230.
   PubMed Web of Science ®Google Scholar
• Jover R, Bort R, Gómez‐Lechón MJ, Castell JV. 2001. Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: A study using adenovirus-mediated antisense targeting. Hepatology. 33(3):668–675.
   PubMed Web of Science ®Google Scholar
• Jukić MM, Opel N, Ström J, Carrillo-Roa T, Miksys S, Novalen M, Renblom A, Sim SC, Peñas-Lledó EM, Courtet P, et al. 2017. Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment. Mol Psychiatry. 22(8):1155–1163.
   PubMed Web of Science ®Google Scholar
• Kane JK, Konu Ö, Ma JZ, Li MD. 2004. Nicotine coregulates multiple pathways involved in protein modification/degradation in rat brain. Mol Brain Res. 132(2):181–191.
   PubMedGoogle Scholar
• Kao T-L, Chen Y-L, Kuan Y-P, Chang W-C, Ho Y-C, Yeh S, Jeng L-B, Ma W-L. 2017. Estrogen-Estrogen Receptor α Signaling Facilitates Bilirubin Metabolism in Regenerating Liver Through Regulating Cytochrome P450 2A6 Expression. Cell Transplant. 26(11):1822–1829.
   PubMed Web of Science ®Google Scholar
• Kar S, Bali KK, Baisantry A, Geffers R, Samii A, Bertalanffy H. 2017. Genome-Wide Sequencing Reveals MicroRNAs Downregulated in Cerebral Cavernous Malformations. J Mol Neurosci. 61(2):178–188.
   PubMed Web of Science ®Google Scholar
• Karlgren M, Backlund M, Johansson I, Oscarson M, Ingelman-Sundberg M. 2004. Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1. Biochem Biophys Res Commun. 315(3):679–685.
   PubMed Web of Science ®Google Scholar
• Kaut O, Schmitt I, Wüllner U. 2012. Genome-scale methylation analysis of Parkinson's disease patients' brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1. Neurogenetics. 13(1):87–91.
   PubMed Web of Science ®Google Scholar
• Kelly SJ, Ostrowski NL, Wilson MA. 1999. Gender differences in brain and behavior: hormonal and neural bases. Pharmacol Biochem Behav. 64(4):655–664.
   PubMed Web of Science ®Google Scholar
• Khandwala AS, Kasper CB. 1973. Preferential induction of aryl hydroxylase activity in rat liver nuclear envelope by 3-methylcholanthrene. Biochem Biophys Res Commun. 54(4):1241–1246.
   PubMed Web of Science ®Google Scholar
• Khokhar JY, Miksys SL, Tyndale RF. 2010. Rat brain CYP2B induction by nicotine is persistent and does not involve nicotinic acetylcholine receptors. Brain Res. 1348:1–9.
   PubMed Web of Science ®Google Scholar
• Khokhar JY, Tyndale RF. 2011. Drug Metabolism within the Brain Changes Drug Response: Selective Manipulation of Brain CYP2B Alters Propofol Effects. Neuropsychopharmacology. 36(3):692–700.
   PubMed Web of Science ®Google Scholar
• Kirches E, Scherlach C,V, Bossanyi P, Schneider T, Szibor R, Kutz E, Warich-Kirches M, Dietzmann K. 1999. MGMT- and P450 3A-inhibitors do not sensitize glioblastoma cell cultures against nitrosoureas. Clin Neuropathol. 18(1):1–8.
   PubMed Web of Science ®Google Scholar
• Kirchheiner J, Seeringer A, Godoy AL, Ohmle B, Maier C, Beschoner P, Sim E-J, Viviani R. 2011. CYP2D6 in the brain: genotype effects on resting brain perfusion. Mol Psychiatry. 16(3):237:333–341.
   Web of Science ®Google Scholar
• Koch WH. 2004. Technology platforms for pharmacogenomic diagnostic assays. Nat Rev Drug Discov. 3(9):749–761.
   PubMed Web of Science ®Google Scholar
• Kodama S, Koike C, Negishi M, Yamamoto Y. 2004. Nuclear Receptors CAR and PXR Cross Talk with FOXO1 To Regulate Genes That Encode Drug-Metabolizing and Gluconeogenic Enzymes. Mol Cell Biol. 24(18):7931–7940.
   PubMed Web of Science ®Google Scholar
• Kohalmy K, Tamási V, Kóbori L, Sárváry E, Pascussi J-M, Porrogi P, Rozman D, Prough RA, Meyer UA, Monostory K. 2007. Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor. Drug Metab Dispos. 35(9):1495–1501.
   PubMed Web of Science ®Google Scholar
• Kojima K, Nagata K, Matsubara T, Yamazoe Y. 2007. Broad but Distinct Role of Pregnane X Receptor on the Expression of Individual Cytochrome P450s in Human Hepatocytes. Drug Metab Pharmacokinet. 22(4):276–286.
   PubMed Web of Science ®Google Scholar
• Kommaddi RP, Turman CM, Moorthy B, Wang L, Strobel HW, Ravindranath V. 2007. An alternatively spliced cytochrome P4501A1 in human brain fails to bioactivate polycyclic aromatic hydrocarbons to DNA-reactive metabolites. J Neurochem. 102(3):867–877.
   PubMed Web of Science ®Google Scholar
• Koskela S, Hakkola J, Hukkanen J, Pelkonen O, Sorri M, Saranen A, Anttila S, Fernandez-Salguero P, Gonzalez F, Raunio H. 1999. Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem Pharmacol. 57(12):1407–1413.
   PubMed Web of Science ®Google Scholar
• Kotrbová V, Mrázová B, Moserová M, Martínek V, Hodek P, Hudeček J, Frei E, Stiborová M. 2011. Cytochrome b(5) shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy. Biochem Pharmacol. 82(6):669–680.
   PubMed Web of Science ®Google Scholar
• Kumar S, Hedges SB. 1998. A molecular timescale for vertebrate evolution. Nature. 392(6679):917–920.
   PubMed Web of Science ®Google Scholar
• Kwon M-S, Seo Y-J, Shim E-J, Choi S-S, Lee J-Y, Suh H-W. 2006. The effect of single or repeated restraint stress on several signal molecules in paraventricular nucleus, arcuate nucleus and locus coeruleus. Neuroscience. 142(4):1281–1292.
   PubMed Web of Science ®Google Scholar
• Lai ZN, Emtner M, Roos P, Nyberg F. 1991. Characterization of putative growth hormone receptors in human choroid plexus. Brain Res. 546(2):222–226.
   PubMed Web of Science ®Google Scholar
• Lamba JK, Lamba V, Yasuda K, Lin YS, Assem M, Thompson E, Strom S, Schuetz E. 2004. Expression of constitutive androstane receptor splice variants in human tissues and their functional consequences. J Pharmacol Exp Ther. 311(2):811–821.
   PubMed Web of Science ®Google Scholar
• Lamba V, Yasuda K, Lamba JK, Assem M, Davila J, Strom S, Schuetz EG. 2004. PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. Toxicol Appl Pharmacol. 199(3):251–265.
   PubMed Web of Science ®Google Scholar
• Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, et al. 2007. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 129(7):1401–1414.
   PubMed Web of Science ®Google Scholar
• Lavery DJ, Lopez-Molina L, Margueron R, Fleury-Olela F, Conquet F, Schibler U, Bonfils C. 1999. Circadian expression of the steroid 15 alpha-hydroxylase (Cyp2a4) and coumarin 7-hydroxylase (Cyp2a5) genes in mouse liver is regulated by the PAR leucine zipper transcription factor DBP. Mol Cell Biol. 19(10):6488–6499.
   PubMed Web of Science ®Google Scholar
• Lee AM, Miksys S, Palmour R, Tyndale RF. 2006. CYP2B6 is expressed in African Green monkey brain and is induced by chronic nicotine treatment. Neuropharmacology. 50(4):441–450.
   PubMed Web of Science ®Google Scholar
• Li J, Xie M, Wang X, Ouyang X, Wan Y, Dong G, Yang Z, Yang J, Yue J. 2015. Sex hormones regulate cerebral drug metabolism via brain miRNAs: down-regulation of brain CYP2D by androgens reduces the analgesic effects of tramadol: Regulation of brain CYP2D by androgens via miRNAs. Br J Pharmacol. 172(19):4639–4654.
   PubMed Web of Science ®Google Scholar
• Lin Y, Wang S, Zhou Z, Guo L, Yu F, Wu B. 2019. Bmal1 regulates circadian expression of cytochrome P450 3a11 and drug metabolism in mice. Commun Biol. 2(1):1–11.
   PubMed Web of Science ®Google Scholar
• Lin YY, Smith LL. 1974. Sterol metabolism XXVIII. Biosynthesis and accumulation of cholest-5-ene-3β, 24-diol (cerebrosterol) in developing rat brain. Biochim Biophys Acta BBA - Lipids Lipid Metab. 348(2):189–196.
   PubMed Web of Science ®Google Scholar
• Ling G, Hauer CR, Gronostajski RM, Pentecost BT, Ding X. 2004. Transcriptional regulation of rat CYP2A3 by nuclear factor 1: identification of a novel NFI-A isoform, and evidence for tissue-selective interaction of NFI with the CYP2A3 promoter in vivo. J Biol Chem. 279(27):27888–27895.
   PubMed Web of Science ®Google Scholar
• Liu F-J, Song X, Yang D, Deng R, Yan B. 2008. The far and distal enhancers in the CYP3A4 gene co-ordinate the proximal promoter in responding similarly to the pregnane X receptor but differentially to hepatocyte nuclear factor-4alpha. Biochem J. 409(1):243–250.
   PubMed Web of Science ®Google Scholar
• Liu M, Zhu Q, Wu J, Yu X, Hu M, Xie X, Yang Z, Yang J, Feng Y-Q, Yue J. 2017. Glutamate affects the production of epoxyeicosanoids within the brain: The up-regulation of brain CYP2J through the MAPK-CREB signaling pathway. Toxicology. 381:31–38.
   PubMed Web of Science ®Google Scholar
• Liu Q, Wang W, Zhang Y, Cui Y, Xu S, Li S. 2020. Bisphenol A regulates cytochrome P450 1B1 through miR-27b-3p and induces carp lymphocyte oxidative stress leading to apoptosis. Fish Shellfish Immunol. 102:489–498.
   PubMed Web of Science ®Google Scholar
• Lobie PE, García-Aragón J, Lincoln DT, Barnard R, Wilcox JN, Waters MJ. 1993. Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. Brain Res Dev Brain Res. 74(2):225–233.
   PubMedGoogle Scholar
• Lu AY, Coon MJ. 1968. Role of hemoprotein P-450 in fatty acid omega-hydroxylation in a soluble enzyme system from liver microsomes. J Biol Chem. 243(6):1331–1332.
   PubMed Web of Science ®Google Scholar
• Lu J, Shang X, Zhong W, Xu Y, Shi R, Wang X. 2020. New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases. Acta Pharm Sin B. 10(1):91–104.
   PubMed Web of Science ®Google Scholar
• Lu Y, Peng Q, Zeng Z, Wang J, Deng Y, Xie L, Mo C, Zeng J, Qin X, Li S. 2014. CYP2D6 phenotypes and Parkinson's disease risk: a meta-analysis. J Neurol Sci. 336(1-2):161–168.
   PubMed Web of Science ®Google Scholar
• Lund EG, Guileyardo JM, Russell DW. 1999. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci USA. 96(13):7238–7243.
   PubMed Web of Science ®Google Scholar
• Ma X, Idle JR, Krausz KW, Gonzalez FJ. 2005. Metabolism of melatonin by human cytochromes p450. Drug Metab Dispos. 33(4):489–494.
   PubMed Web of Science ®Google Scholar
• Mahnke A, Strotkamp D, Roos PH, Hanstein WG, Chabot GG, Nef P. 1997. Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver. Arch Biochem Biophys. 337(1):62–68.
   PubMed Web of Science ®Google Scholar
• Makia NL, Surapureddi S, Monostory K, Prough RA, Goldstein JA. 2014. Regulation of Human CYP2C9 Expression by Electrophilic Stress Involves Activator Protein 1 Activation and DNA Looping. Mol Pharmacol. 86(2):125–137.
   PubMed Web of Science ®Google Scholar
• Malaplate-Armand C, Ferrari L, Masson C, Visvikis-Siest S, Lambert H, Batt AM. 2005. Down-regulation of astroglial CYP2C, glucocorticoid receptor and constitutive androstane receptor genes in response to cocaine in human U373 MG astrocytoma cells. Toxicol Lett. 159(3):203–211.
   PubMed Web of Science ®Google Scholar
• Mann A, Miksys S, Lee A, Mash DC, Tyndale RF. 2008. Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment. Neuropharmacology. 55(7):1147–1155.
   PubMed Web of Science ®Google Scholar
• Mann A, Miksys SL, Gaedigk A, Kish SJ, Mash DC, Tyndale RF. 2012. The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients. Neurobiol Aging. 33(9):2160–2171.
   PubMed Web of Science ®Google Scholar
• Mann A, Tyndale RF. 2010. Cytochrome P450 2D6 enzyme neuroprotects against 1-methyl-4-phenylpyridinium toxicity in SH-SY5Y neuronal cells. Eur J Neurosci. 31(7):1185–1193.
   PubMed Web of Science ®Google Scholar
• Manzella C, Singhal M, Alrefai WA, Saksena S, Dudeja PK, Gill RK. 2018. Serotonin is an endogenous regulator of intestinal CYP1A1 via AhR. Sci Rep. 8(1):6103.
   PubMed Web of Science ®Google Scholar
• Manzella CR, Ackerman M, Singhal M, Ticho AL, Ceh J, Alrefai WA, Saksena S, Dudeja PK, Gill RK. 2020. Serotonin Modulates AhR Activation by Interfering with CYP1A1-Mediated Clearance of AhR Ligands. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol. 54(1):126–141.
   PubMedGoogle Scholar
• Marini S, Nannelli A, Sodini D, Dragoni S, Valoti M, Longo V, Gervasi PG. 2007. Expression, microsomal and mitochondrial activities of cytochrome P450 enzymes in brain regions from control and phenobarbital-treated rabbits. Life Sci. 80(10):910–917.
   PubMed Web of Science ®Google Scholar
• Martignoni M, Groothuis GMM, de Kanter R. 2006. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol. 2(6):875–894.
   PubMed Web of Science ®Google Scholar
• Martis S, Peter I, Hulot J-S, Kornreich R, Desnick RJ, Scott SA. 2013. Multi-ethnic Distribution of Clinically Relevant CYP2C Genotypes and Haplotypes. Pharmacogenomics J. 13(4):369–377.
   PubMed Web of Science ®Google Scholar
• McCarthy MM, Auger AP, Bale TL, De Vries GJ, Dunn GA, Forger NG, Murray EK, Nugent BM, Schwarz JM, Wilson ME. 2009. The epigenetics of sex differences in the brain. J Neurosci. 29(41):12815–12823.
   PubMed Web of Science ®Google Scholar
• McDougle DR, Kambalyal A, Meling DD, Das A. 2014. Endocannabinoids Anandamide and 2-Arachidonoylglycerol Are Substrates for Human CYP2J2 Epoxygenase. J Pharmacol Exp Ther. 351(3):616–627.
   PubMed Web of Science ®Google Scholar
• McFadyen MCE, Melvin WT, Murray GI. 1998. Regional Distribution of Individual Forms of Cytochrome P450 mRNA in Normal Adult Human Brain. Biochem Pharmacol. 55(6):825–830.
   PubMed Web of Science ®Google Scholar
• McMillan DM, Miksys S, Tyndale RF. 2019. Rat brain CYP2D activity alters in vivo central oxycodone metabolism, levels and resulting analgesia. Addict Biol. 24(2):228–238.
   PubMed Web of Science ®Google Scholar
• McMillan DM, Tyndale RF. 2015. Nicotine increases codeine analgesia through the induction of brain CYP2D and central activation of codeine to morphine. Neuropsychopharmacol. 40(7):1804–1812.
   PubMed Web of Science ®Google Scholar
• McMillan DM, Tyndale RF. 2017. Inducing rat brain CYP2D with nicotine increases the rate of codeine tolerance; predicting the rate of tolerance from acute analgesic response. Biochem Pharmacol. 145:158–168.
   PubMed Web of Science ®Google Scholar
• McMillan DM, Tyndale RF. 2018. CYP-mediated drug metabolism in the brain impacts drug response. Pharmacol Ther. 184:189–200.
   PubMed Web of Science ®Google Scholar
• Messina ES, Tyndale RF, Sellers EM. 1997. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther. 282(3):1608–1614.
   PubMed Web of Science ®Google Scholar
• Mestres J. 2004. Structure conservation in cytochromes P450. Proteins. 58(3):596–609.
   Web of Science ®Google Scholar
• Meyer RP, Gehlhaus M, Knoth R, Volk B. 2007. Expression and function of cytochrome p450 in brain drug metabolism. Curr Drug Metab. 8(4):297–306.
   PubMed Web of Science ®Google Scholar
• Meyer RP, Gehlhaus M, Schwab R, Bürck C, Knoth R, Hagemeyer CE. 2009. Concordant up-regulation of cytochrome P450 Cyp3a11, testosterone oxidation and androgen receptor expression in mouse brain after xenobiotic treatment. J Neurochem. 109(2):670–681.
   PubMed Web of Science ®Google Scholar
• Meyer RP, Hagemeyer CE, Knoth R, Kaufmann MR, Volk B. 2006. Anti-epileptic drug phenytoin enhances androgen metabolism and androgen receptor expression in murine hippocampus. J Neurochem. 96(2):460–472.
   PubMed Web of Science ®Google Scholar
• Meyer RP, Podvinec M, Meyer UA. 2002. Cytochrome P450 CYP1A1 Accumulates in the Cytosol of Kidney and Brain and Is Activated by Heme. Mol Pharmacol. 62(5):1061–1067.
   PubMed Web of Science ®Google Scholar
• Michaud V, Bar-Magen T, Turgeon J, Flockhart D, Desta Z, Wainberg MA. 2012. The Dual Role of Pharmacogenetics in HIV Treatment: Mutations and Polymorphisms Regulating Antiretroviral Drug Resistance and Disposition. Pharmacol Rev. 64(3):803–833.
   PubMed Web of Science ®Google Scholar
• Miki Y, Suzuki T, Tazawa C, Blumberg B, Sasano H. 2005. Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues. Mol Cell Endocrinol. 231(1-2):75–85.
   PubMed Web of Science ®Google Scholar
• Miksys S, Hoffmann E, Tyndale RF. 2000. Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment. Biochem Pharmacol. 59(12):1501–1511.
   PubMed Web of Science ®Google Scholar
• Miksys S, Lerman C, Shields PG, Mash DC, Tyndale RF. 2003. Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology. 45(1):122–132.
   PubMed Web of Science ®Google Scholar
• Miksys S, Rao Y, Hoffmann E, Mash DC, Tyndale RF. 2002. Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics: CYP2D6 is higher in brain of human alcoholics. J Neurochem. 82(6):1376–1387.
   PubMed Web of Science ®Google Scholar
• Miksys S, Tyndale R. 2013. Cytochrome P450-mediated drug metabolism in the brain. J Psychiatry Neurosci. 38(3):152–163.
   PubMed Web of Science ®Google Scholar
• Miksys S, Tyndale RF. 2004. The Unique Regulation of Brain Cytochrome P450 2 (CYP2) family enzymes by drugs and genetics. Drug Metab Rev. 36(2):313–333.
   PubMed Web of Science ®Google Scholar
• Miksys S, Wadji FB, Tolledo EC, Remington G, Nobrega JN, Tyndale RF. 2017. Rat brain CYP2D enzymatic metabolism alters acute and chronic haloperidol side-effects by different mechanisms. Prog Neuropsychopharmacol Biol Psychiatry. 78:140–148.
   PubMed Web of Science ®Google Scholar
• Miksys SL, Cheung C, Gonzalez FJ, Tyndale RF. 2005. Human CYP2D6 and mouse CYP2DS: organ distribution in a humanized mouse model. Drug Metab Dispos. 33(10):1495–1502.
   PubMed Web of Science ®Google Scholar
• Miller RT, Miksys S, Hoffmann E, Tyndale RF. 2014. Ethanol self-administration and nicotine treatment increase brain levels of CYP2D in African green monkeys. Br J Pharmacol. 171(12):3077–3088.
   PubMed Web of Science ®Google Scholar
• Misteli T, Soutoglou E. 2009. The emerging role of nuclear architecture in DNA repair and genome maintenance. Nat Rev Mol Cell Biol. 10(4):243–254.
   PubMed Web of Science ®Google Scholar
• Mizukami Y, Sogawa K, Suwa Y, Muramatsu M, Fujii-Kuriyama Y. 1983. Gene structure of a phenobarbital-inducible cytochrome P-450 in rat liver. Proc Natl Acad Sci USA. 80(13):3958–3962.
   PubMed Web of Science ®Google Scholar
• Mo A, Mukamel EA, Davis FP, Luo C, Henry GL, Picard S, Urich MA, Nery JR, Sejnowski TJ, Lister R, et al. 2015. Epigenomic Signatures of Neuronal Diversity in the Mammalian Brain. Neuron. 86(6):1369–1384.
   PubMed Web of Science ®Google Scholar
• Molofsky AV, Hochstim C, Deneen B, Rowitch D. 2013. Mechanisms of Astrocyte Development (Chapter 36). Blood Vessels. 20.
   Google Scholar
• Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, et al. 2000. Orphan Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Share Xenobiotic and Steroid Ligands. J Biol Chem. 275(20):15122–15127.
   PubMed Web of Science ®Google Scholar
• Moran JH, Mitchell LA, Bradbury JA, Qu W, Zeldin DC, Schnellmann RG, Grant DF. 2000. Analysis of the cytotoxic properties of linoleic acid metabolites produced by renal and hepatic P450s. Toxicol Appl Pharmacol. 168(3):268–279.
   PubMed Web of Science ®Google Scholar
• Murray GI, Pritchard S, Melvin WT, Burke MD. 1995. Cytochrome P450 CYP3A5 in the human anterior pituitary gland. FEBS Lett. 364(1):79–82.
   PubMed Web of Science ®Google Scholar
• Muskhelishvili L, Thompson PA, Kusewitt DF, Wang C, Kadlubar FF. 2001. In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues. J Histochem Cytochem. 49(2):229–236.
   PubMed Web of Science ®Google Scholar
• Na S, Li J, Zhang H, Li Y, Yang Z, Zhong Y, Dong G, Yang J, Yue J. 2017. The induction of cytochrome P450 2E1 by ethanol leads to the loss of synaptic proteins via PPARα down-regulation. Toxicology. 385:18–27.
   PubMed Web of Science ®Google Scholar
• Nagelhus EA, Ottersen OP. 2013. Physiological roles of aquaporin-4 in brain. Physiol Rev. 93(4):1543–1562.
   PubMed Web of Science ®Google Scholar
• Nannelli A, Rossignolo F, Tolando R, Rossato P, Pellegatti M, Longo V, Gervasi PG. 2010. Expression and distribution of CYP3A genes, CYP2B22, and MDR1, MRP1, MRP2, LRP efflux transporters in brain of control and rifampicin-treated pigs. Mol Cell Biochem. 337(1-2):133–143.
   PubMed Web of Science ®Google Scholar
• Nebert DW, Dalton TP, Okey AB, Gonzalez FJ. 2004. Role of Aryl Hydrocarbon Receptor-mediated Induction of the CYP1 Enzymes in Environmental Toxicity and Cancer. J Biol Chem. 279(23):23847–23850.
   PubMed Web of Science ®Google Scholar
• Nebert DW, Russell DW. 2002. Clinical importance of the cytochromes P450. The Lancet. 360(9340):1155–1162.
   PubMed Web of Science ®Google Scholar
• Nelson DR. 2011. Progress in tracing the evolutionary paths of cytochrome P450. Biochim Biophys Acta. 1814(1):14–18.
   PubMed Web of Science ®Google Scholar
• Nishikura K. 2016. A-to-I editing of coding and non-coding RNAs by ADARs. Nat Rev Mol Cell Biol. 17(2):83–96.
   PubMed Web of Science ®Google Scholar
• Nishimura M, Naito S, Yokoi T. 2004. Tissue-specific mRNA Expression Profiles of Human Nuclear Receptor Subfamilies. Drug Metab Pharmacokinet. 19(2):135–149.
   PubMedGoogle Scholar
• Niwa T, Shizuku M, Yamano K. 2017. Effect of genetic polymorphism on the inhibition of dopamine formation from p-tyramine catalyzed by brain cytochrome P450 2D6 . Arch Biochem Biophys. 620:23–27.
   PubMed Web of Science ®Google Scholar
• Niwa T, Yabusaki Y, Honma K, Matsuo N, Tatsuta K, Ishibashi F, Katagiri M. 1998. Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica. 28(6):539–547.
   PubMed Web of Science ®Google Scholar
• Norman BJ, Neal RA. 1976. Examination of the metabolism in vitro of parathion (diethyl p-nitrophenyl phosphorothionate) by rat lung and brain. Biochem Pharmacol. 25(1):37–45.
   PubMed Web of Science ®Google Scholar
• Norris PJ, Hardwick JP, Emson PC. 1996. Regional distribution of cytochrome P450 2D1 in the rat central nervous system. J Comp Neurol. 366(2):244–258.
   PubMed Web of Science ®Google Scholar
• Nozaki K, Nakano M, Iwakami C, Fukami T, Nakajima M. 2019. RNA Editing Enzymes Modulate the Expression of Hepatic CYP2B6, CYP2C8, and Other Cytochrome P450 Isoforms. Drug Metab Dispos. 47(6):639–647.
   PubMed Web of Science ®Google Scholar
• Nyberg F, Burman P. 1996. Growth hormone and its receptors in the central nervous system-location and functional significance. Horm Res. 45(1-2):18–22.
   PubMedGoogle Scholar
• Obata Y, Castaño Á, Boeing S, Bon-Frauches AC, Fung C, Fallesen T, de Agüero MG, Yilmaz B, Lopes R, Huseynova A, et al. 2020. Neuronal programming by microbiota regulates intestinal physiology. Nature. 578(7794):284–289.
   PubMed Web of Science ®Google Scholar
• Oesch-Bartlomowicz B, Oesch F. 2003. Cytochrome-P450 phosphorylation as a functional switch. Arch Biochem Biophys. 409(1):228–234.
   PubMed Web of Science ®Google Scholar
• Oesch-Bartlomowicz B, Oesch F. 2005. Phosphorylation of cytochromes P450: first discovery of a posttranslational modification of a drug-metabolizing enzyme. Biochem Biophys Res Commun. 338(1):446–449.
   PubMed Web of Science ®Google Scholar
• Ohe T, Hirobe M, Mashino T. 2000. Novel metabolic pathway of estrone and 17beta-estradiol catalyzed by cytochrome P-450. Drug Metab Dispos. 28(2):110–112.
   PubMed Web of Science ®Google Scholar
• Oladimeji P, Cui H, Zhang C, Chen T. 2016. Regulation of PXR and CAR by protein-protein interaction and signaling crosstalk. Expert Opin Drug Metab Toxicol. 12(9):997–1010.
   PubMed Web of Science ®Google Scholar
• Omura T, Sato R. 1962. A new cytochrome in liver microsomes. J Biol Chem. 237:1375–1376.
   PubMed Web of Science ®Google Scholar
• Omura T, Sato R. 1964. The carbon monoxide-binding pigment of liver microsomes. I. evidence for its hemoprotein nature. J Biol Chem. 239:2370–2378.
   PubMed Web of Science ®Google Scholar
• Otyepka M, Skopalík J, Anzenbacherová E, Anzenbacher P. 2007. What common structural features and variations of mammalian P450s are known to date? Biochim Biophys Acta BBA - Gen Subj. 1770(3):376–389.
   PubMed Web of Science ®Google Scholar
• Ou‐Yang D-S, Huang S-L, Wang W, Xie H-G, Xu Z-H, Shu Y, Zhou H-H. 2000. Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population. Br J Clin Pharmacol. 49(2):145–151.
   PubMed Web of Science ®Google Scholar
• Pai HV, Upadhya SC, Chinta SJ, Hegde SN, Ravindranath V. 2002. Differential metabolism of alprazolam by liver and brain cytochrome (P4503A) to pharmacologically active metabolite. Pharmacogenomics J. 2(4):243–258.
   PubMedGoogle Scholar
• Pan X, Lee Y-K, Jeong H. 2015. Farnesoid X Receptor Agonist Represses Cytochrome P450 2D6 Expression by Upregulating Small Heterodimer Partner. Drug Metab Dispos. 43(7):1002–1007.
   PubMed Web of Science ®Google Scholar
• Park H-J, Choi Y-J, Kim JW, Chun H-S, Im I, Yoon S, Han Y-M, Song C-W, Kim H. 2015. Differences in the Epigenetic Regulation of Cytochrome P450 Genes between Human Embryonic Stem Cell-Derived Hepatocytes and Primary Hepatocytes. Aalto-Setala K, editor. PLoS One. 10(7):p. e0132992.
   Google Scholar
• Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, Lehmann JM. 1999. Bile acids: natural ligands for an orphan nuclear receptor. Science. 284(5418):1365–1368.
   PubMed Web of Science ®Google Scholar
• Parvez M, Qhanya LB, Mthakathi NT, Kgosiemang IKR, Bamal HD, Pagadala NS, Xie T, Yang H, Chen H, Theron CW, et al. 2016. Molecular evolutionary dynamics of cytochrome P450 monooxygenases across kingdoms: Special focus on mycobacterial P450s. Sci Rep. 6:33099
   PubMed Web of Science ®Google Scholar
• Pedersen RS, Brasch-Andersen C, Sim SC, Bergmann TK, Halling J, Petersen MS, Weihe P, Edvardsen H, Kristensen VN, Brøsen K, et al. 2010. Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations. Eur J Clin Pharmacol. 66(12):1199–1205.
   PubMed Web of Science ®Google Scholar
• Penaloza CG, Estevez B, Han DM, Norouzi M, Lockshin RA, Zakeri Z. 2014. Sex-dependent regulation of cytochrome P450 family members Cyp1a1, Cyp2e1, and Cyp7b1 by methylation of DNA. Faseb J. 28(2):966–977.
   PubMed Web of Science ®Google Scholar
• Peñas-LLedó EM, Dorado P, Pacheco R, González I, LLerena A. 2009. Relation between CYP2D6 genotype, personality, neurocognition and overall psychopathology in healthy volunteers. Pharmacogenomics. 10(7):1111–1120.
   PubMed Web of Science ®Google Scholar
• Peng Z, Wu T, Li Y, Xu Z, Zhang S, Liu B, Chen Q, Tian D. 2016. MicroRNA-370-3p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting β-catenin. Brain Res. 1644:53–61.
   PubMed Web of Science ®Google Scholar
• Petersen SL, Curran MA, Marconi SA, Carpenter CD, Lubbers LS, McAbee MD. 2000. Distribution of mRNAs encoding the arylhydrocarbon receptor, arylhydrocarbon receptor nuclear translocator, and arylhydrocarbon receptor nuclear translocator-2 in the rat brain and brainstem. J Comp Neurol. 427(3):428–439.
   PubMed Web of Science ®Google Scholar
• Phillips JD, Kushner JP, Bergonia HA, Franklin MR. 2011. Uroporphyria in the Cyp1a2-/- mouse. Blood Cells Mol Dis. 47(4):249–254.
   PubMed Web of Science ®Google Scholar
• Pla A, Pascual M, Renau-Piqueras J, Guerri C. 2014. TLR4 mediates the impairment of ubiquitin-proteasome and autophagy-lysosome pathways induced by ethanol treatment in brain. Cell Death Dis. 5(2):e1066
   PubMed Web of Science ®Google Scholar
• Polimanti R, Jensen KP, Gelernter J. 2017. Phenome-wide association study for CYP2A6 alleles: rs113288603 is associated with hearing loss symptoms in elderly smokers. Sci Rep. 7(1):1–7.
   PubMed Web of Science ®Google Scholar
• Poulos TL, Finzel BC, Howard AJ. 1987. High-resolution crystal structure of cytochrome P450cam. J Mol Biol. 195(3):687–700.
   PubMed Web of Science ®Google Scholar
• Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U, Schibler U. 2002. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell. 110(2):251–260.
   PubMed Web of Science ®Google Scholar
• Raivich G, Behrens A. 2006. Role of the AP-1 transcription factor c-Jun in developing, adult and injured brain. Prog Neurobiol. 78(6):347–363.
   PubMed Web of Science ®Google Scholar
• Raw I, Petragnani N, Nogueira OC. 1960. Studies of electron transport enzymes. IV. Oxidation and reduction of cytochrome b5 by rat liver mitochondria. J Biol Chem. 235:1517–1520.
   PubMed Web of Science ®Google Scholar
• Rehfeld F, Rohde AM, Nguyen DTT, Wulczyn FG. 2015. Lin28 and let-7: ancient milestones on the road from pluripotency to neurogenesis. Cell Tissue Res. 359(1):145–160.
   PubMed Web of Science ®Google Scholar
• Relling MV, Lin JS, Ayers GD, Evans WE. 1992. Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clin Pharmacol Ther. 52(6):643–658.
   PubMed Web of Science ®Google Scholar
• Ren S, Nguyen L, Wu S, Encinas C, Adams JS, Hewison M. 2005. Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis. J Biol Chem. 280(21):20604–20611.
   PubMed Web of Science ®Google Scholar
• Rezvani K, Teng Y, Shim D, Biasi MD. 2007. Nicotine regulates multiple synaptic proteins by inhibiting proteasomal activity. J Neurosci. 27(39):10508–10519.
   PubMed Web of Science ®Google Scholar
• Rieder CR, Ramsden DB, Williams AC. 1998. Cytochrome P450 1B1 mRNA in the human central nervous system. Mol Pathol. 51(3):138–142.
   PubMedGoogle Scholar
• Rieger JK, Klein K, Winter S, Zanger UM. 2013. Expression variability of absorption, distribution, metabolism, excretion-related microRNAs in human liver: influence of nongenetic factors and association with gene expression. Drug Metab Dispos. 41(10):1752–1762.
   PubMed Web of Science ®Google Scholar
• Ripperger JA. 2006. Mapping of binding regions for the circadian regulators BMAL1 and CLOCK within the mouse Rev-erbalpha gene. Chronobiol Int. 23(1-2):135–142.
   PubMedGoogle Scholar
• Ripperger JA, Schibler U. 2006. Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions. Nat Genet. 38(3):369–374.
   PubMed Web of Science ®Google Scholar
• Robertson GR, Field J, Goodwin B, Bierach S, Tran M, Lehnert A, Liddle C. 2003. Transgenic Mouse Models of Human CYP3A4 Gene Regulation. Mol Pharmacol. 64(1):42–50.
   PubMed Web of Science ®Google Scholar
• Rose AS, Bradley AR, Valasatava Y, Duarte JM, Prlic A, Rose PW. 2018. NGL viewer: web-based molecular graphics for large complexes. Bioinformatics. 34(21):3755–3758.
   PubMed Web of Science ®Google Scholar
• Rosenbrock H, Hagemeyer CE, Ditter M, Knoth R, Volk B. 2001. Identification, induction and localization of cytochrome P450s of the 3A-subfamily in mouse brain. Neurotox Res. 3(4):339–349.
   PubMed Web of Science ®Google Scholar
• Rosenbrock H, Hagemeyer CE, Singeç I, Knoth R, Volk B. 1999. Testosterone metabolism in rat brain is differentially enhanced by phenytoin-inducible cytochrome P450 isoforms. J Neuroendocrinol. 11(8):597–604.
   PubMed Web of Science ®Google Scholar
• Ryan KJ, Engel LL. 1957. Hydroxylation of steroids at carbon 21. J Biol Chem. 225(1):103–114.
   PubMed Web of Science ®Google Scholar
• Saeki M, Saito Y, Nagano M, Teshima R, Ozawa S, Sawada J. 2002. mRNA expression of multiple cytochrome p450 isozymes in four types of cultured skin cells. Int Arch Allergy Immunol. 127(4):333–336.
   PubMed Web of Science ®Google Scholar
• Sagara Y, Harano T, Omura T. 1978. Characterization of electron transport enzymes in the envelope of rat liver nuclei. J Biochem. 83(3):807–812.
   PubMed Web of Science ®Google Scholar
• Sahar S, Sassone-Corsi P. 2012. Regulation of metabolism: the circadian clock dictates the time. Trends Endocrinol Metab. 23(1):1–8.
   PubMed Web of Science ®Google Scholar
• Sakai Y, Meno C, Fujii H, Nishino J, Shiratori H, Saijoh Y, Rossant J, Hamada H. 2001. The retinoic acid-inactivating enzyme CYP26 is essential for establishing an uneven distribution of retinoic acid along the anterio-posterior axis within the mouse embryo. Genes Dev. 15(2):213–225.
   PubMed Web of Science ®Google Scholar
• Sasame HA, Ames MM, Nelson SD. 1977. Cytochrome P-450 and NADPH cytochrome c reductase in rat brain: formation of catechols and reactive catechol metabolites. Biochem Biophys Res Commun. 78(3):919–926.
   PubMed Web of Science ®Google Scholar
• Sato TK, Panda S, Miraglia LJ, Reyes TM, Rudic RD, McNamara P, Naik KA, FitzGerald GA, Kay SA, Hogenesch JB. 2004. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron. 43(4):527–537.
   PubMed Web of Science ®Google Scholar
• Scandlyn MJ, Stuart EC, Rosengren RJ. 2008. Sex-specific differences in CYP450 isoforms in humans. Expert Opin Drug Metab Toxicol. 4(4):413–424.
   PubMed Web of Science ®Google Scholar
• Schiering C, Wincent E, Metidji A, Iseppon A, Li Y, Potocnik AJ, Omenetti S, Henderson CJ, Wolf CR, Nebert DW, et al. 2017. Feedback control of AHR signalling regulates intestinal immunity. Nature. 542(7640):242–245.
   PubMed Web of Science ®Google Scholar
• Schilter B, Omiecinski CJ. 1993. Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain. Mol Pharmacol. 44(5):990–996.
   PubMed Web of Science ®Google Scholar
• Schwarz D, Kisselev P, Schunck W-H, Chernogolov A, Boidol W, Cascorbi I, Roots I. 2000. Allelic variants of human cytochrome p450 1A1 (CYP1A1): effect of T461N and I462V substitutions on steroid hydroxylase specificity. Pharmacogenetics. 10(6):519–530.
   PubMedGoogle Scholar
• Seng JE, Gandy J, Turturro A, Lipman R, Bronson RT, Parkinson A, Johnson W, Hart RW, Leakey JE. 1996. Effects of caloric restriction on expression of testicular cytochrome P450 enzymes associated with the metabolic activation of carcinogens. Arch Biochem Biophys. 335(1):42–52.
   PubMed Web of Science ®Google Scholar
• Sezutsu H, Le Goff G, Feyereisen R. 2013. Origins of P450 diversity. Philos Trans R Soc Lond B Biol Sci. 368(1612):20120428.
   PubMed Web of Science ®Google Scholar
• Shawahna R, Uchida Y, Declèves X, Ohtsuki S, Yousif S, Dauchy S, Jacob A, Chassoux F, Daumas-Duport C, Couraud P-O, et al. 2011. Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels. Mol Pharm. 8(4):1332–1341.
   PubMed Web of Science ®Google Scholar
• Shehin SE, Stephenson RO, Greenlee WF. 2000. Transcriptional regulation of the human CYP1B1 gene. Evidence for involvement of an aryl hydrocarbon receptor response element in constitutive expression. J Biol Chem. 275(10):6770–6776.
   PubMed Web of Science ®Google Scholar
• Shou M, Korzekwa KR, Brooks EN, Krausz KW, Gonzalez FJ, Gelboin HV. 1997. Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone. Carcinogenesis. 18(1):207–214.
   PubMed Web of Science ®Google Scholar
• Siegle I, Fritz P, Eckhardt K, Zanger UM, Eichelbaum M. 2001. Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain. Pharmacogenetics. 11(3):237–245.
   PubMedGoogle Scholar
• Sim SC, Nordin L, Andersson TM-L, Virding S, Olsson M, Pedersen NL, Ingelman-Sundberg M. 2010. Association between CYP2C19 polymorphism and depressive symptoms. Am J Med Genet Part B Neuropsychiatr Genet off Publ Int Soc Psychiatr Genet. 153B. (6):1160–1166.
   Web of Science ®Google Scholar
• Sinclair PR, Gorman N, Tsyrlov IB, Fuhr U, Walton HS, Sinclair JF. 1998. Uroporphyrinogen oxidation catalyzed by human cytochromes P450. Drug Metab Dispos. 26(10):1019–1025.
   PubMed Web of Science ®Google Scholar
• Singh AK, Kashyap MP, Jahan S, Kumar V, Tripathi VK, Siddiqui MA, Yadav S, Khanna VK, Das V, Jain SK, et al. 2012. Expression and inducibility of cytochrome P450s (CYP1A1, 2B6, 2E1, 3A4) in human cord blood CD34(+) stem cell-derived differentiating neuronal cells. Toxicol Sci off J Soc Toxicol. 129(2):392–410.
   PubMed Web of Science ®Google Scholar
• Singh S, Singh K, Patel S, Patel DK, Singh C, Nath C, Singh MP. 2008. Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse. Brain Res. 1207:193–206.
   PubMed Web of Science ®Google Scholar
• Sinues B, Fanlo A, Mayayo E, Carcas C, Vicente J, Arenaz I, Cebollada A. 2008. CYP2A6 activity in a healthy Spanish population: effect of age, sex, smoking, and oral contraceptives. Hum Exp Toxicol. 27(5):367–372.
   PubMed Web of Science ®Google Scholar
• Snider NT, Sikora MJ, Sridar C, Feuerstein TJ, Rae JM, Hollenberg PF. 2008. The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6. J Pharmacol Exp Ther. 327(2):538–545.
   PubMed Web of Science ®Google Scholar
• Song H-R, Gonzalez-Gomez I, Suh GS, Commins DL, Sposto R, Gilles FH, Deneen B, Erdreich-Epstein A. 2010. Nuclear factor IA is expressed in astrocytomas and is associated with improved survival. Neuro-Oncol. 12(2):122–132.
   PubMed Web of Science ®Google Scholar
• Šrejber M, Navrátilová V, Paloncýová M, Bazgier V, Berka K, Anzenbacher P, Otyepka M. 2018. Membrane-attached mammalian cytochromes P450: An overview of the membrane's effects on structure, drug binding, and interactions with redox partners. J Inorg Biochem. 183:117–136.
   PubMed Web of Science ®Google Scholar
• Srinivasan V, Smits M, Spence W, Lowe AD, Kayumov L, Pandi-Perumal SR, Parry B, Cardinali DP. 2006. Melatonin in mood disorders. World J Biol Psychiatry. 7(3):138–151.
   PubMed Web of Science ®Google Scholar
• Stahl SM. 2013. Stahl's essential psychopharmacology: neuroscientific basis and practical applications. 4th ed. Cambridge (UK): Cambridge University Press.
   Google Scholar
• Stapleton G, Steel M, Richardson M, Mason JO, Rose KA, Morris RG, Lathe R. 1995. A Novel Cytochrome P450 Expressed Primarily in Brain. J Biol Chem. 270(50):29739–29745.
   PubMed Web of Science ®Google Scholar
• Sterrenburg L, Gaszner B, Boerrigter J, Santbergen L, Bramini M, Elliott E, Chen A, Peeters BWMM, Roubos EW, Kozicz T. 2011. Chronic stress induces sex-specific alterations in methylation and expression of corticotropin-releasing factor gene in the rat. PLoS One. 6(11):e28128
   PubMed Web of Science ®Google Scholar
• Stiborová M, Frei E, Wiessler M, Schmeiser HH. 2001. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2. Chem Res Toxicol. 14(8):1128–1137.
   PubMed Web of Science ®Google Scholar
• Stingl JC. 2018. Mindful Pharmacogenetics: Drug Dosing for Mental Health. Am J Psychiatry. 175(5):395–397.
   PubMed Web of Science ®Google Scholar
• Stingl JC, Esslinger C, Tost H, Bilek E, Kirsch P, Ohmle B, Viviani R, Walter H, Rietschel M, Meyer-Lindenberg A. 2012. Genetic variation in CYP2D6 impacts neural activation during cognitive tasks in humans. Neuroimage. 59(3):2818–2823.
   PubMed Web of Science ®Google Scholar
• Su T, Ding X. 2004. Regulation of the cytochrome P450 2A genes. Toxicol Appl Pharmacol. 199(3):285–294.
   PubMed Web of Science ®Google Scholar
• Sueyoshi T, Kawamoto T, Zelko I, Honkakoski P, Negishi M. 1999. The Repressed Nuclear Receptor CAR Responds to Phenobarbital in Activating the Human CYP2B6 Gene. J Biol Chem. 274(10):6043–6046.
   PubMed Web of Science ®Google Scholar
• Swindell EC, Thaller C, Sockanathan S, Petkovich M, Jessell TM, Eichele G. 1999. Complementary domains of retinoic acid production and degradation in the early chick embryo. Dev Biol. 216(1):282–296.
   PubMed Web of Science ®Google Scholar
• Takahashi JS, Hong H-K, Ko CH, McDearmon EL. 2008. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet. 9(10):764–775.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Oda Y, Toyoda Y, Fukami T, Yokoi T, Nakajima M. 2014. Regulation of cytochrome b5 expression by miR-223 in human liver: effects on cytochrome P450 activities. Pharm Res. 31(3):780–794.
   PubMed Web of Science ®Google Scholar
• Taneja G, Maity S, Jiang W, Moorthy B, Coarfa C, Ghose R. 2019. Transcriptomic profiling identifies novel mechanisms of transcriptional regulation of the cytochrome P450 (Cyp) 3a11 gene. Sci Rep. 9(1):1–13.
   PubMed Web of Science ®Google Scholar
• Tietz DR, Colthart AM, Pochapsky SS, Pochapsky TC. 2017. Substrate recognition by two different P450s: Evidence for conserved roles in a common fold. Sci Rep. 7(1):1–9.
   PubMed Web of Science ®Google Scholar
• Tordjman S, Chokron S, Delorme R, Charrier A, Bellissant E, Jaafari N, Fougerou C. 2017. Melatonin: Pharmacology, Functions and Therapeutic Benefits. Curr Neuropharmacol. 15(3):434–443.
   PubMed Web of Science ®Google Scholar
• Toselli F, Booth Depaz IM, Worrall S, Etheridge N, Dodd PR, Wilce PA, Gillam EMJ. 2015. Expression of CYP2E1 and CYP2U1 Proteins in Amygdala and Prefrontal Cortex: Influence of Alcoholism and Smoking. Alcohol Clin Exp Res. 39(5):790–797.
   PubMed Web of Science ®Google Scholar
• Toselli F, Dodd PR, Gillam EMJ. 2016. Emerging roles for brain drug-metabolizing cytochrome P450 enzymes in neuropsychiatric conditions and responses to drugs. Drug Metab Rev. 48(3):379–404.
   PubMed Web of Science ®Google Scholar
• Trabzuni D, Ramasamy A, Imran S, Walker R, Smith C, Weale ME, Hardy J, Ryten M, North American Brain Expression Consortium 2013. Widespread sex differences in gene expression and splicing in the adult human brain. Nat Commun. 4(1):2771.
   PubMed Web of Science ®Google Scholar
• Tsuruo Y, Ishimura K, Fujita H, Osawa Y. 1994. Immunocytochemical localization of aromatase-containing neurons in the rat brain during pre- and postnatal development. Cell Tissue Res. 278(1):29–39.
   PubMed Web of Science ®Google Scholar
• Turman CM, Hatley JM, Ryder DJ, Ravindranath V, Strobel HW. 2006. Alternative splicing within the human cytochrome P450 superfamily with an emphasis on the brain: The convolution continues. Expert Opin Drug Metab Toxicol. 2(3):399–418.
   PubMed Web of Science ®Google Scholar
• Twardowschy CA, Werneck LC, Scola RH, Borgio JG, De Paola L, Silvado C. 2013. The role of CYP2C9 polymorphisms in phenytoin-related cerebellar atrophy. Seizure. 22(3):194–197.
   PubMed Web of Science ®Google Scholar
• Tyndale RF, Pianezza ML, Sellers EM. 1999. A common genetic defect in nicotine metabolism decreases risk for dependence and lowers cigarette consumption. Nicotine Tob Res. 1 Suppl 2 Suppl (2):S63–S67. discussion S69-70.
   PubMedGoogle Scholar
• Ueda R, Iketaki H, Nagata K, Kimura S, Gonzalez FJ, Kusano K, Yoshimura T, Yamazoe Y. 2006. A Common Regulatory Region Functions Bidirectionally in Transcriptional Activation of the Human CYP1A1 and CYP1A2 Genes. Mol Pharmacol. 69(6):1924–1930.
   PubMed Web of Science ®Google Scholar
• Uehara S, Uno Y, Inoue T, Murayama N, Shimizu M, Sasaki E, Yamazaki H. 2015. Activation and Deactivation of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine by Cytochrome P450 Enzymes and Flavin-Containing Monooxygenases in Common Marmosets (Callithrix jacchus). Drug Metab Dispos. 43(5):735–742.
   PubMed Web of Science ®Google Scholar
• Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C, Sjöstedt E, Asplund A. 2015. Tissue-based map of the human proteome. Science. 347(6220):1260419.
   PubMed Web of Science ®Google Scholar
• Upadhya SC, Tirumalai PS, Boyd MR, Mori T, Ravindranath V. 2000. Cytochrome P4502E (CYP2E) in brain: constitutive expression, induction by ethanol and localization by fluorescence in situ hybridization. Arch Biochem Biophys. 373(1):23–34.
   Google Scholar
• Veeravigrom M, Jaroonvanichkul V, Netbaramee W, Phaisarn P, Uyathanarat T. 2016. Phenytoin toxicity in two-month-old Thai infant with CYP2C9 gene polymorphism-A case report. Brain Dev. 38(1):136–138.
   PubMed Web of Science ®Google Scholar
• Viitala P, Posti K, Lindfors A, Pelkonen O, Raunio H. 2001. cAMP Mediated Upregulation of CYP2A5 in Mouse Hepatocytes. Biochem Biophys Res Commun. 280(3):761–767.
   PubMed Web of Science ®Google Scholar
• Volk B, Hettmannsperger U, Papp T, Amelizad Z, Oesch F, Knoth R. 1991. Mapping of phenytoin-inducible cytochrome P450 immunoreactivity in the mouse central nervous system. Neuroscience. 42(1):215–235.
   PubMed Web of Science ®Google Scholar
• Von Bahr C, Ursing C, Yasui N, Tybring G, Bertilsson L, Röjdmark S. 2000. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects - An indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin. Eur J Clin Pharmacol. 56(2):123–127.
   PubMed Web of Science ®Google Scholar
• von Richter O, Pitarque M, Rodríguez-Antona C, Testa A, Mantovani R, Oscarson M, Ingelman-Sundberg M. 2004. Polymorphic NF-Y dependent regulation of human nicotine C-oxidase (CYP2A6). Pharmacogenetics. 14(6):369–379.
   PubMedGoogle Scholar
• Wade RC, Winn PJ, Schlichting I. Sudarko   2004. A survey of active site access channels in cytochromes P450. J Inorg Biochem. 98(7):1175–1182.
   PubMed Web of Science ®Google Scholar
• Walsh AA, Szklarz GD, Scott EE. 2013. Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism. J Biol Chem. 288(18):12932–12943.
   PubMed Web of Science ®Google Scholar
• Walton R, Kimber M, Rockett K, Trafford C, Kwiatkowski D, Sirugo G. 2005. Haplotype block structure of the cytochrome P450 CYP2C gene cluster on chromosome 10. Nat Genet. 37(9):915–916.
   PubMed Web of Science ®Google Scholar
• Wang H, Donley KM, Keeney DS, Hoffman SMG. 2003. Organization and evolution of the Cyp2 gene cluster on mouse chromosome 7, and comparison with the syntenic human cluster. Environ Health Perspect. 111(15):1835–1842.
   PubMed Web of Science ®Google Scholar
• Wang H, Kawashima H, Strobel HW. 1996. cDNA Cloning of a novel CYP3A from rat brain. Biochem Biophys Res Commun. 221(1):157–162.
   PubMed Web of Science ®Google Scholar
• Wang H, Negishi M. 2003. Transcriptional Regulation of Cytochrome P450 2B Genes by Nuclear Receptors. Curr Drug Metab. 4(6):515–525.
   PubMed Web of Science ®Google Scholar
• Wang H, Strobel HW. 1997. Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli. Arch Biochem Biophys. 344(2):365–372.
   PubMed Web of Science ®Google Scholar
• Wang Q, Han X, Li J, Gao X, Wang Y, Liu M, Dong G, Yue J. 2015. Regulation of cerebral CYP2D alters tramadol metabolism in the brain: interactions of tramadol with propranolol and nicotine. Xenobiotica. 45(4):335–344.
   PubMed Web of Science ®Google Scholar
• Warner M, Köhler C, Hansson T, Gustafsson JA. 1988. Regional distribution of cytochrome P-450 in the rat brain: spectral quantitation and contribution of P-450b,e, and P-450c,d. J Neurochem. 50(4):1057–1065.
   PubMed Web of Science ®Google Scholar
• White JA, Ramshaw H, Taimi M, Stangle W, Zhang A, Everingham S, Creighton S, Tam S-P, Jones G, Petkovich M. 2000. Identification of the human cytochrome P450, P450RAI-2, which is predominantly expressed in the adult cerebellum and is responsible for all-trans-retinoic acid metabolism. Proc Natl Acad Sci USA. 97(12):6403–6408.
   PubMed Web of Science ®Google Scholar
• Williams PA, Cosme J, Sridhar V, Johnson EF, McRee DE. 2000. Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. Mol Cell. 5(1):121–131.
   PubMed Web of Science ®Google Scholar
• Wojnowski L. 2004. Genetics of the variable expression of CYP3A in humans. Ther Drug Monit. 26(2):192–199.
   PubMed Web of Science ®Google Scholar
• Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, O'Donnell J, Christensen DJ, Nicholson C, Iliff JJ, et al. 2013. Sleep drives metabolite clearance from the adult brain. Science. 342(6156):373–377.
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Shaw PM, Guengerich FP, Shimada T. 1998. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem Res Toxicol. 11(6):659–665.
   PubMed Web of Science ®Google Scholar
• Yanagimoto T, Itoh S, Sawada M, Hashimoto H, Kamataki T. 1994. Molecular cloning and functional expression of a mouse cytochrome P-450 (Cyp3a-13): examination of Cyp3a-13 enzyme to activate aflatoxin B1 (AFB1). Biochim Biophys Acta. 1201(3):405–410.
   PubMed Web of Science ®Google Scholar
• Yanagimoto T, Itoh S, Sawada M, Kamataki T. 1997. Mouse cytochrome P450 (Cyp3a11): predominant expression in liver and capacity to activate aflatoxin B1. Arch Biochem Biophys. 340(2):215–218.
   PubMed Web of Science ®Google Scholar
• Yang X, Zhang B, Molony C, Chudin E, Hao K, Zhu J, Gaedigk A, Suver C, Zhong H, Leeder JS, et al. 2010. Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res. 20(8):1020–1036.
   PubMed Web of Science ®Google Scholar
• Yasukochi Y, Satta Y. 2015. Molecular Evolution of the CYP2D Subfamily in Primates: Purifying Selection on Substrate Recognition Sites without the Frequent or Long-Tract Gene Conversion. Genome Biol Evol. 7(4):1053–1067.
   PubMed Web of Science ®Google Scholar
• Ye W, Chen R, Chen X, Huang B, Lin R, Xie X, Chen J, Jiang J, Deng Y, Wen J. 2019. AhR regulates the expression of human cytochrome P450 1A1 (CYP1A1) by recruiting Sp1. Febs J. 286(21):4215–4231.
   PubMed Web of Science ®Google Scholar
• Yoshida R, Nakajima M, Nishimura K, Tokudome S, Kwon J-T, Yokoi T. 2003. Effects of polymorphism in promoter region of human CYP2A6 gene (CYP2A6*9) on expression level of messenger ribonucleic acid and enzymatic activity in vivo and in vitro. Clin Pharmacol Ther. 74(1):69–76.
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Noshiro M, Aoyama Y, Kawamoto T, Horiuchi T, Gotoh O. 1997. Structural and evolutionary studies on sterol 14-demethylase P450 (CYP51), the most conserved P450 monooxygenase: II. Evolutionary analysis of protein and gene structures. J Biochem. 122(6):1122–1128.
   PubMed Web of Science ®Google Scholar
• Yu A-M, Idle JR, Byrd LG, Krausz KW, Küpfer A, Gonzalez FJ. 2003. Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6. Pharmacogenetics. 13(3):173–181.
   PubMedGoogle Scholar
• Yu X, Wu J, Hu M, Wu J, Zhu Q, Yang Z, Xie X, Feng Y-Q, Yue J. 2019. Glutamate affects the CYP1B1- and CYP2U1-mediated hydroxylation of arachidonic acid metabolism via astrocytic mGlu5 receptor. Int J Biochem Cell Biol. 110:111–121.
   PubMed Web of Science ®Google Scholar
• Yue J, Miksys S, Hoffmann E, Tyndale RF. 2008. Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course. J Psychiatry Neurosci JPN. 33(1):54–63.
   PubMed Web of Science ®Google Scholar
• Yun C-H, Ahn T, Guengerich FP, Yamazaki H, Shimada T. 1999. Phospholipase D Activity of Cytochrome P450 in Human Liver Endoplasmic Reticulum. Arch Biochem Biophys. 367(1):81–88.
   PubMed Web of Science ®Google Scholar
• Zastrozhin MS, Smirnov VV, Petukhov AE, Pankratenko EP, Zastrozhina AK, Grishina EA, Ryzhikova KA, Bure IV, Skryabin VY, Vlasovskih RV, et al. 2020. The influence of concentration of micro-RNA hsa-miR-370-3p and CYP2D6*4 on equilibrium concentration of mirtazapine in patients with major depressive disorder. Psychopharmacol Bull. 50(3):58–75.
   PubMedGoogle Scholar
• Zeng L, Chen Y, Wang Y, Yu L-R, Knox B, Chen J, Shi T, Chen S, Ren Z, Guo L, et al. 2017. MicroRNA hsa-miR-370-3p suppresses the expression and induction of CYP2D6 by facilitating mRNA degradation. Biochem Pharmacol. 140:139–149.
   PubMed Web of Science ®Google Scholar
• Zhang F, Li J, Na S, Wu J, Yang Z, Xie X, Wan Y, Li K, Yue J. 2018. The involvement of PPARs in the selective regulation of brain CYP2D by growth hormone. Neuroscience. 379:115–125.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ding X. 1998. Identification and characterization of a novel tissue-specific transcriptional activating element in the 5'-flanking region of the CYP2A3 gene predominantly expressed in rat olfactory mucosa . J Biol Chem. 273(36):23454–23462.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang QY, Guo J, Zhou Y, Ding X. 2000. Identification and functional characterization of a conserved, nuclear factor 1-like element in the proximal promoter region of CYP1A2 gene specifically expressed in the liver and olfactory mucosa. J Biol Chem. 275(12):8895–8902.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Dong G, Luo H, Cao J, Wang C, Wu J, Feng Y-Q, Yue J. 2012. Induction of brain CYP2E1 by chronic ethanol treatment and related oxidative stress in hippocampus, cerebellum, and brainstem. Toxicology. 302(2-3):275–284.
   PubMed Web of Science ®Google Scholar
• Zhou K, Khokhar JY, Zhao B, Tyndale RF. 2013. First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivo. Biochem Pharmacol. 85(12):1848–1855.
   PubMed Web of Science ®Google Scholar
• Zhuge J, Yu Y-N. 2004. Three new alternative splicing variants of human cytochrome P450 2D6 mRNA in human extratumoral liver tissue. World J Gastroenterol. 10(22):3356–3360.
   PubMed Web of Science ®Google Scholar
• Zimatkin SM, Pronko SP, Vasiliou V, Gonzalez FJ, Deitrich RA. 2006. Enzymatic mechanisms of ethanol oxidation in the brain. Alcohol Clin Exp Res. 30(9):1500–1505.
   PubMed Web of Science ®Google Scholar